Clinical Trial Update: Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating anlotinib in combination with vinorelbine for HER2-negative advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN